A more specific clinical manifestation is the somatostatinoma syndrome characterized by diabetes, cholelithiasis and steatorrhoea.1 Moreover, hypoglycaemia has been associated with somatostatin‐secreting neuroendocrine tumours.2, 3, 4 The pathogenesis of hypoglycaemia in patients with somatostatinoma has not been well characterized. Here, SST is linked to diabetes mellitus.